Skip to content

Cubii for Exercise in People With MS

Feasibility, Acceptability, and Preliminary Efficacy of Cubii Under-desk Elliptical for Exercise in People With Multiple Sclerosis (PwMS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05826431
Acronym
Cubii
Enrollment
21
Registered
2023-04-24
Start date
2023-04-19
Completion date
2023-12-04
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Activity, Motor, Fatigue, Multiple Sclerosis, Quality of Life

Brief summary

The goals of this observational study are to evaluate (1) the feasibility, usability, and satisfaction with the Cubii elliptical and (2) the preliminary efficacy of the Cubii elliptical for increasing activity (primary outcome), physical function, and quality of life, and decreasing physical and psychological symptom (e.g., pain, fatigue, depression) severity in people with MS. The main question it aims to answer is how usable and feasible is the Cubii as a mode of exercise for people with MS? Participants will use the Cubii as they choose and keep a written log of this use. They will answer questions about their demographics, MS disease-related variables (e.g., pain, fatigue, falls), activity, exercise, quality of life, and biopsychosocial symptom variables) and provide additional data regarding the feasibility, usability, and satisfaction with use of the Cubii.

Detailed description

Data indicates people with MS are less active than their peers in the general population. Exercise interventions are important non-pharmacologic approach to maximize function and quality of life for people living with MS. Based on current evidence and expert opinion, the National Multiple Sclerosis Society (NMSS) recommends that healthcare providers promote the benefits of exercise and lifestyle physical activity for every person with MS. Individuals with at least moderate impairments (approximately 50% of MS population) often require adaptive exercise due to mobility and balance impairments. These individuals are likely to present with neurologic impairments that impact their gait and/or coordination and may experience limitations in walking distance and necessitate precautions for falls, as well as the use of assistive devices or compensatory strategies. The Cubii product line is well-placed for this subset of the MS population because it allows for safe, seated exercise that can still meet the recommendations for aerobic and resistance training. This study will capitalize on a representative, heterogeneous sample of MS patients who are seeking to change their coping behaviors around MS, including by exercising more, and an existing exercise unit that can be utilized by people with a range of mobility.

Interventions

DEVICECubii elliptical

Low impact, portable, and compact elliptical for seated use.

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Participants will use the equipment for two months as they choose, keep a log of their use, and answer pre- and post- participation questionnaires.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Clinician-confirmed MS * 18 years of age or older * Walks with the aid of an assistive device (e.g., cane, walker, forearm crutches) * Able to read and speak English * Lives in the greater Seattle metropolitan area * All genders * Has an iPhone or Android phone that can download apps

Exclusion criteria

\- People unable to exercise for health reasons

Design outcomes

Primary

MeasureTime frameDescription
Average Daily UseBaseline - Week 9Average minutes participants used the device each day
Change in Activity - Godin Leisure Time Exercise Questionnaire[Baseline, Week 9The Godin Leisure-Time Exercise Questionnaire (GLTEQ; Godin & Shephard, 1985) is a 4-item self-administered questionnaire seeking information re: the number of times one engages in mild, moderate and strenuous leisure-time physical activity bouts of at least 15 min duration in a typical week. The GLTEQ was used to assess the frequency of typical weekly strenuous, moderate, and mild exercise. Total exercise scores were also computed by multiplying each reported exercise frequency by its metabolic equivalent (MET) and then summing the totals: (strenuous x 9) + (moderate x 5) + (mild x 2) (Godin, Jobin, & Boullon, 1986). Higher scores indicate greater exercise engagement.
Change in Activity - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 - Physical Function 20a[Baseline, Week 9The tool asks participants to rate the difficulty in performing twenty common activities of daily living using scale that ranges from 1-5, where 1=unable to do and 5=without any difficulty. The total raw score is calculated by summing the individual responses. A higher score indicates higher function.
Device UtilizationBaseline - Week 9Qualitative findings: a narrative summary of participant responses to interview questions about using the device.

Secondary

MeasureTime frameDescription
Change in Depression - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 Depression 8a[Baseline, Week 9A structured, self-report questionnaire consisting of 8 items examining negative mood (sadness, guilt), view of self (self-criticism, worthlessness), and social cognition (loneliness, interpersonal alienation) as well as decreased positive affect and engagement (loss of interest, meaning, and purpose). Respondents rate the strength of agreement with statements about depressive symptoms using a 1-5 scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always). The total raw score is calculated by summing the individual responses. The raw score ranges from 8-40; a higher score reflects more severe depressive symptoms. The total raw score is translated into a T-score for each participant according to the PROMIS Scoring Manual. The T-score provides a standardized score with a mean of 50 and a standard deviation of 10.
Change in Quality of Life - Multiple Sclerosis Quality of Life-54 (MSQOL54) Quality of Life Subscale[Baseline, Week 9A structured, self-report questionnaire examining quality of life that contains 54-items, generating 12 subscales with two summary scores (physical health and mental health) and two additional single-item measures (satisfaction with sexual function and change in health). In scoring the MSQOL-54, two summary scores (physical and mental health) are produced from a weighted combination of scale scores, where scores range from 0 to 100. A higher score indicates improved quality of life.
Change in Fatigue Intensity - Brief Fatigue Inventory (BFI)[Baseline, Week 9The BFI is a 9-item, 11-point rating scale developed to assess subjective fatigue. The first three questions measure fatigue severity from 0, indicating no fatigue, to 10, indicating as bad as you can imagine, at current, usual, and worst levels. The following six questions assess fatigue interference with daily activities including general activity, mood, walking ability, normal work (both inside and outside the home), relations with other people, and enjoyment of life. Response options range from 0, indicating does not interfere, to 10, indicating, completely interferes. Higher scores on the BFI correspond to greater self-reported levels of fatigue. The time period for all questions is over the past 24 hours.
Change in Anxiety - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Anxiety 8a[Baseline, Week 9A structured, self-report questionnaire consisting of 6 items examining anxiety symptoms in the past 7 days using a 5-point scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always). The lowest possible raw score is 6; the highest possible raw score is 30. Higher results mean greater anxiety symptoms. The total raw score is translated into a T-score for each participant according to the PROMIS Scoring Manual. The T-score provides a standardized score with a mean of 50 and a standard deviation of 10.
Change in Pain Intensity - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Short Form 3a[Baseline, Week 9Patient-reported pain intensity consisting of 3 items assessing pain intensity over the past seven days. Each item is scored 1 (no pain) to 5 (very severe pain) yielding a raw score between 3 to 15, which is converted to a standard t-score. Higher scores indicate greater self-reported intensity of pain.
Change in Pain Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Scale (Short Form 8b, V1.0)[Baseline, Week 9A structured, self-report questionnaire consisting of 8 items measuring the self-reported consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities (e.g., how much did pain interfere with your day-to-day activities). Each item is scored 1 (not at all) to 5 (very much).The total raw score is calculated by summing the individual responses. The raw score ranges from 8-40; a higher score reflects more severe depressive symptoms. The total raw score is translated into a T-score for each participant according to the PROMIS Scoring Manual. The T-score provides a standardized score with a mean of 50 and a standard deviation of 10.
Change in Fatigue Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Fatigue-Multiple Sclerosis 8a[Baseline, Week 9]A structured, self-report questionnaire consisting of 21 statements examining the effects of fatigue. Each statement is scored on a scale of 0-4 (0 = never, 1 = rarely, 2 = sometimes, 3 = often, 4 = almost always). The total MFIS score can range from 0-84; the higher the score, the stronger the feelings of fatigue.

Countries

United States

Participant flow

Participants by arm

ArmCount
Participants Using Cubii
Participants will use the Cubii exercise unit at their homes for two months as they choose. They will maintain a log regarding their use of the device. They will complete validated self-report questionnaires (demographics, MS disease-related variables (e.g., pain, fatigue, falls), activity, exercise, quality of life, and biopsychosocial symptom variables) before and after the use of the exercise unit. Cubii elliptical: Low impact, portable, and compact elliptical for seated use.
20
Total20

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicParticipants Using Cubii
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
5 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
20 Participants
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Average Daily Use

Average minutes participants used the device each day

Time frame: Baseline - Week 9

ArmMeasureValue (MEAN)Dispersion
Participants Using CubiiAverage Daily Use19.72 MinutesStandard Deviation 0.59
Primary

Change in Activity - Godin Leisure Time Exercise Questionnaire

The Godin Leisure-Time Exercise Questionnaire (GLTEQ; Godin & Shephard, 1985) is a 4-item self-administered questionnaire seeking information re: the number of times one engages in mild, moderate and strenuous leisure-time physical activity bouts of at least 15 min duration in a typical week. The GLTEQ was used to assess the frequency of typical weekly strenuous, moderate, and mild exercise. Total exercise scores were also computed by multiplying each reported exercise frequency by its metabolic equivalent (MET) and then summing the totals: (strenuous x 9) + (moderate x 5) + (mild x 2) (Godin, Jobin, & Boullon, 1986). Higher scores indicate greater exercise engagement.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Activity - Godin Leisure Time Exercise QuestionnaireBaseline25.95 units on a scaleStandard Deviation 40.73
Participants Using CubiiChange in Activity - Godin Leisure Time Exercise QuestionnaireWeek 944.60 units on a scaleStandard Deviation 85.76
Comparison: Study analyses were conducted using IBM SPSS Statistics Version 29. Frequencies and descriptive data were tabulated to describe the sample and quantify device use, satisfaction, and perceived impact. Qualitative responses regarding usability and feasibility were summarized based on the themes of the responses.p-value: 0.153Paired samples t-test
Primary

Change in Activity - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 - Physical Function 20a

The tool asks participants to rate the difficulty in performing twenty common activities of daily living using scale that ranges from 1-5, where 1=unable to do and 5=without any difficulty. The total raw score is calculated by summing the individual responses. A higher score indicates higher function.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Activity - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 - Physical Function 20aBaseline40.49 units on a scaleStandard Deviation 2.54
Participants Using CubiiChange in Activity - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 - Physical Function 20aWeek 941.10 units on a scaleStandard Deviation 2.22
p-value: 0.103Paired samples t-test
Primary

Device Utilization

Qualitative findings: a narrative summary of participant responses to interview questions about using the device.

Time frame: Baseline - Week 9

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Participants Using CubiiDevice UtilizationParticipants reporting being very satisfied or satisfied with the Cubii as an exercise device.14 Participants
Participants Using CubiiDevice UtilizationParticipants reporting being very likely or likely to continue to use their Cubii.18 Participants
Participants Using CubiiDevice UtilizationParticipants reporting they were likely to recommend the device to other people with MS.17 Participants
Participants Using CubiiDevice UtilizationParticipants reporting improvement in quality of life.14 Participants
Participants Using CubiiDevice UtilizationParticipants reporting improvement in physical function.13 Participants
Participants Using CubiiDevice UtilizationParticipants reporting improvement in activity level.14 Participants
Secondary

Change in Anxiety - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Anxiety 8a

A structured, self-report questionnaire consisting of 6 items examining anxiety symptoms in the past 7 days using a 5-point scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always). The lowest possible raw score is 6; the highest possible raw score is 30. Higher results mean greater anxiety symptoms. The total raw score is translated into a T-score for each participant according to the PROMIS Scoring Manual. The T-score provides a standardized score with a mean of 50 and a standard deviation of 10.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Anxiety - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Anxiety 8aBaseline48.72 units on a scaleStandard Deviation 10.24
Participants Using CubiiChange in Anxiety - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Anxiety 8aWeek 945.90 units on a scaleStandard Deviation 9.4
p-value: 0.0483Paired samples t-test
Secondary

Change in Depression - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 Depression 8a

A structured, self-report questionnaire consisting of 8 items examining negative mood (sadness, guilt), view of self (self-criticism, worthlessness), and social cognition (loneliness, interpersonal alienation) as well as decreased positive affect and engagement (loss of interest, meaning, and purpose). Respondents rate the strength of agreement with statements about depressive symptoms using a 1-5 scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always). The total raw score is calculated by summing the individual responses. The raw score ranges from 8-40; a higher score reflects more severe depressive symptoms. The total raw score is translated into a T-score for each participant according to the PROMIS Scoring Manual. The T-score provides a standardized score with a mean of 50 and a standard deviation of 10.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Depression - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 Depression 8aBaseline48.20 units on a scaleStandard Deviation 11.04
Participants Using CubiiChange in Depression - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 Depression 8aWeek 948.15 units on a scaleStandard Deviation 9.51
p-value: 0.483Paired samples t-test
Secondary

Change in Fatigue Intensity - Brief Fatigue Inventory (BFI)

The BFI is a 9-item, 11-point rating scale developed to assess subjective fatigue. The first three questions measure fatigue severity from 0, indicating no fatigue, to 10, indicating as bad as you can imagine, at current, usual, and worst levels. The following six questions assess fatigue interference with daily activities including general activity, mood, walking ability, normal work (both inside and outside the home), relations with other people, and enjoyment of life. Response options range from 0, indicating does not interfere, to 10, indicating, completely interferes. Higher scores on the BFI correspond to greater self-reported levels of fatigue. The time period for all questions is over the past 24 hours.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Fatigue Intensity - Brief Fatigue Inventory (BFI)Baseline6.60 units on a scaleStandard Deviation 2.53
Participants Using CubiiChange in Fatigue Intensity - Brief Fatigue Inventory (BFI)Week 96.18 units on a scaleStandard Deviation 2.34
p-value: 0.123Paired samples t-test
Secondary

Change in Fatigue Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Fatigue-Multiple Sclerosis 8a

A structured, self-report questionnaire consisting of 21 statements examining the effects of fatigue. Each statement is scored on a scale of 0-4 (0 = never, 1 = rarely, 2 = sometimes, 3 = often, 4 = almost always). The total MFIS score can range from 0-84; the higher the score, the stronger the feelings of fatigue.

Time frame: [Baseline, Week 9]

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Fatigue Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Fatigue-Multiple Sclerosis 8aBaseline59.36 units on a scaleStandard Deviation 6.88
Participants Using CubiiChange in Fatigue Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Fatigue-Multiple Sclerosis 8aWeek 959.39 units on a scaleStandard Deviation 5.83
p-value: 0.487Paired samples t-test
Secondary

Change in Pain Intensity - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Short Form 3a

Patient-reported pain intensity consisting of 3 items assessing pain intensity over the past seven days. Each item is scored 1 (no pain) to 5 (very severe pain) yielding a raw score between 3 to 15, which is converted to a standard t-score. Higher scores indicate greater self-reported intensity of pain.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Pain Intensity - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Short Form 3aBaseline54.21 units on a scaleStandard Deviation 9.22
Participants Using CubiiChange in Pain Intensity - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Short Form 3aWeek 953.95 units on a scaleStandard Deviation 8.99
p-value: 441Paired samples t-test
Secondary

Change in Pain Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Scale (Short Form 8b, V1.0)

A structured, self-report questionnaire consisting of 8 items measuring the self-reported consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities (e.g., how much did pain interfere with your day-to-day activities). Each item is scored 1 (not at all) to 5 (very much).The total raw score is calculated by summing the individual responses. The raw score ranges from 8-40; a higher score reflects more severe depressive symptoms. The total raw score is translated into a T-score for each participant according to the PROMIS Scoring Manual. The T-score provides a standardized score with a mean of 50 and a standard deviation of 10.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Pain Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Scale (Short Form 8b, V1.0)Baseline54.72 units on a scaleStandard Deviation 8.23
Participants Using CubiiChange in Pain Interference - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Scale (Short Form 8b, V1.0)Week 957.32 units on a scaleStandard Deviation 9.82
p-value: 0.095Paired samples t-test
Secondary

Change in Quality of Life - Multiple Sclerosis Quality of Life-54 (MSQOL54) Quality of Life Subscale

A structured, self-report questionnaire examining quality of life that contains 54-items, generating 12 subscales with two summary scores (physical health and mental health) and two additional single-item measures (satisfaction with sexual function and change in health). In scoring the MSQOL-54, two summary scores (physical and mental health) are produced from a weighted combination of scale scores, where scores range from 0 to 100. A higher score indicates improved quality of life.

Time frame: [Baseline, Week 9

ArmMeasureGroupValue (MEAN)Dispersion
Participants Using CubiiChange in Quality of Life - Multiple Sclerosis Quality of Life-54 (MSQOL54) Quality of Life SubscaleBaseline59.74 units on a scaleStandard Deviation 13.27
Participants Using CubiiChange in Quality of Life - Multiple Sclerosis Quality of Life-54 (MSQOL54) Quality of Life SubscaleWeek 963.95 units on a scaleStandard Deviation 16.62
p-value: 0.083Paired samples t-test

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026